Faes C - Search Results

1

On the estimation of the reproduction number based on misreported epidemic data.

Azmon A, Faes C, Hens N. Azmon A, et al. Among authors: faes c. Stat Med. 2014 Mar 30;33(7):1176-92. doi: 10.1002/sim.6015. Epub 2013 Oct 10. Stat Med. 2014. PMID: 24122943

2

On the use of historical control data in pre-clinical safety studies.

Marringwa JT, Faes C, Aerts M, Geys H, Teuns G, Van Den Poel B, Bijnens L. Marringwa JT, et al. Among authors: faes c. J Biopharm Stat. 2007;17(3):493-509. doi: 10.1080/10543400701216355. J Biopharm Stat. 2007. PMID: 17479396

3

A high-dimensional joint model for longitudinal outcomes of different nature.

Faes C, Aerts M, Molenberghs G, Geys H, Teuns G, Bijnens L. Faes C, et al. Stat Med. 2008 Sep 30;27(22):4408-27. doi: 10.1002/sim.3314. Stat Med. 2008. PMID: 18551509

4

Analysis of cross-over designs with serial correlation within periods using semi-parametric mixed models.

Maringwa JT, Geys H, Shkedy Z, Faes C, Molenberghs G, Aerts M, Van Ammel K, Teisman A, Bijnens L. Maringwa JT, et al. Among authors: faes c. Stat Med. 2008 Dec 10;27(28):6009-33. doi: 10.1002/sim.3363. Stat Med. 2008. PMID: 18613252

5

Application of semiparametric mixed models and simultaneous confidence bands in a cardiovascular safety experiment with longitudinal data.

Maringwa JT, Geys H, Shkedy Z, Faes C, Molenberghs G, Aerts M, Ammel KV, Teisman A, Bijnens L. Maringwa JT, et al. Among authors: faes c. J Biopharm Stat. 2008;18(6):1043-62. doi: 10.1080/10543400802368881. J Biopharm Stat. 2008. PMID: 18991107

6

Seventy-five years of estimating the force of infection from current status data.

Hens N, Aerts M, Faes C, Shkedy Z, Lejeune O, Van Damme P, Beutels P. Hens N, et al. Among authors: faes c. Epidemiol Infect. 2010 Jun;138(6):802-12. doi: 10.1017/S0950268809990781. Epub 2009 Sep 21. Epidemiol Infect. 2010. PMID: 19765352

7

European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009).

Versporten A, Coenen S, Adriaenssens N, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group. Versporten A, et al. Among authors: faes c. J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi13-23. doi: 10.1093/jac/dkr454. J Antimicrob Chemother. 2011. PMID: 22096062

8

European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009).

Versporten A, Coenen S, Adriaenssens N, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group. Versporten A, et al. Among authors: faes c. J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi25-35. doi: 10.1093/jac/dkr455. J Antimicrob Chemother. 2011. PMID: 22096063

9

European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009).

Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group. Adriaenssens N, et al. Among authors: faes c. J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi3-12. doi: 10.1093/jac/dkr453. J Antimicrob Chemother. 2011. PMID: 22096064

10

European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009).

Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group. Adriaenssens N, et al. Among authors: faes c. J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi37-45. doi: 10.1093/jac/dkr456. J Antimicrob Chemother. 2011. PMID: 22096065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters